Identifying lung cancer at its earliest stage before symptoms develop allows for earlier treatment and the potential for cure ...

The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).

It is further described as a targeted therapy "designed to improve outcomes in patients who have tried all other treatment ...

Doctors might call Ann Malik of Rhode Island an outlier; we would call her a thriver. Malik was diagnosed with stage four lung cancer at the age of 39, given just one month to live. Today, she is ten ...

After unusual symptoms forced him to retire from his job, Gerardo Bada was diagnosed with lung cancer after visiting the ...

July 17, 2024 — A medication used to treat diabetic neuropathy may make chemotherapy treatments more effective for patients with lung cancer, according to new ... New Study Finds 40-Percent of ...

The FDA approved ensartinib (Ensacove) as a first-line treatment for adults with ALK -positive locally advanced or metastatic ...

"The state of lung cancer for 2024 reports that the five year survival rates for anyone diagnosed within the state of Rhode ...

2024 — Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive ... A New Ventilator-on-a-Chip Model to ...

Researchers at the Icahn School of Medicine at Mount Sinai have identified the mechanism of action of a treatment for ...

Over a 45-years span — between 1975 and 2020 — improvements in cancer screenings and prevention strategies have reduced ...